WBA - Walgreens Boots Alliance - Stock Forecast

Healthcare - Sector
Coverage Profile Stock analysts Price Targets & Ratings Chart Insider Trading

WBA is currently covered by 16 analysts with an average price target of $23.06. This is a potential upside of $12.09 (110.21%) from yesterday's end of day stock price of $10.97.

Walgreens Boots Alliance's activity chart (see below) currently has 384 price targets and 352 ratings on display. The stock rating distribution of WBA is 67.82% HOLD, 10.34% BUY and 21.84% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 17.59% with an average time for these price targets to be met of 75.74 days.

Highest price target for WBA is $22, Lowest price target is $7, average price target is $13.17.

Most recent stock forecast was given by GEORGE HILL from DEUTSCHE BANK on 28-Feb-2025. First documented stock forecast 24-Jun-2013.

Overview

Walgreens Boots Alliance generates revenue primarily through its two segments, the United States and International.

The United States segment

Sells prescription drugs and a wide range of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. Walgreens uses Duane Reade stores, a popular retail drugstore chains in the United States, to sell these products. The segment also provides central specialty pharmacy services and mail services.

The International segment

Operates pharmacy-led health and beauty retail stores and optical practices in various countries. This segment sells prescription drugs, health and wellness products, beauty and personal care products, and other consumer products. Walgreens uses the Boots, Benavides, and Ahumada retail stores to sell products, as well as through the company’s boots.com website and an integrated mobile application.

The company also offers various services and programs, including retail pharmacy services, specialty pharmacy services, patient support programs, and data analytics services. Revenue is generated through fees and other payments from partnerships and collaborations with.

History

Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Currently out of the existing stock ratings of WBA, 59 are a HOLD (67.82%), 9 are a BUY (10.34%), 19 are a SELL (21.84%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$9

$-2.01 (-18.26%)

$13

2 months ago
(28-Feb-2025)

4/31 (12.9%)

$-2.23 (-19.86%)

136

Hold

$12

$0.99 (8.99%)

$13

2 months 28 days ago
(31-Jan-2025)

3/21 (14.29%)

$1.72 (16.73%)

140

Hold

$12

$0.99 (8.99%)

$13

3 months 13 days ago
(15-Jan-2025)

2/9 (22.22%)

$-0.53 (-4.23%)

20

Hold

$11

$-0.01 (-0.09%)

$9

3 months 15 days ago
(13-Jan-2025)

3/16 (18.75%)

$-0.9 (-7.56%)

89

Sell

$8.5

$-2.51 (-22.80%)

$7.5

3 months 15 days ago
(13-Jan-2025)

1/4 (25%)

$-3.4 (-28.57%)

3

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is WBA (Walgreens Boots Alliance) average time for price targets to be met?

On average it took 75.74 days on average for the stock forecasts to be realized with a an average price target met ratio 17.59

Which analyst has the current highest performing score on WBA (Walgreens Boots Alliance) with a proven track record?

AJAY JAIN

Which analyst has the most public recommendations on WBA (Walgreens Boots Alliance)?

Ajay Jain has 7 price targets and 5 ratings on WBA

Which analyst is the currently most bullish on WBA (Walgreens Boots Alliance)?

Ralph Giacobbe with highest potential upside - $83.99

Which analyst is the currently most reserved on WBA (Walgreens Boots Alliance)?

Stephanie Davis with lowest potential downside - -$4.01

Walgreens Boots Alliance in the News

Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down

Walgreens Boots Alliance, Inc. WBA delivered adjusted earnings per share (EPS) of 63 cents in the second quarter of fiscal 2025, down 47.5% from the year-ago quarter’s figure (down 47.3% at constant exchange rate or CER). However, the figure topped the Zacks Consensus Estimate by 18.9%. Find the latest EPS estimates and surprises on Zacks...

Tariffs Won't Stop Walgreens Buyout, Barclays Says

Walgreens Boots Alliance’s leveraged buyout by Sycamore Partners will likely go ahead in the fourth quarter despite market turmoil from new U.S. tariffs, according to bond analysts at Barclays. Sycamore pulled out of its proposed buyout of Victoria’s Secret owner L Brands in 2020, arguing that the pandemic triggered a “material adverse change,” or MAC,...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?